Company: HURA
Filing Date: 2025-11-03
Form Type: 8-K
Source: 0001193125-25-262562
Chunk: 1

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-03
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(b) Pro forma financial information

The following unaudited pro forma financial information of TuHURA is attached as Exhibit 99.3 to this Report and incorporated by reference herein:

  Unaudited Pro Forma Condensed Combined Balance Sheet for TuHURA as of June 29, 2025, on a pro forma basis as if the merger transaction with Kineta, Inc. that closed on June 30, 2025 (the “ Kine...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Unaudited Pro Forma Condensed Combined Statements of Operations for TuHURA for the period ended June 29, 2025, on a pro forma basis as if the Transactions had been consummated on January 1, 2024  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Unaudited Pro Forma Condensed Combined Statement of Operations for TuHURA for the year ended December 31, 2024, on a pro forma basis as if the Transactions had been consummated on January 1, 2024  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Notes to Unaudited Pro Forma Condensed Consolidated Financial Statements  

(d) Exhibits

  Exhibit No                                                                                                                                                                                      
        99.1      Updates Regarding Business                                                                                                                                                      
        99.2      Risk Factors                                                                                                                                                                    
        99.3      Unaudited Pro Forma Condensed Combined Financial Information of TuHURA Biosciences, Inc. as of and for the period ended June 29, 2025 and for the year ended December 31, 2024  
         104      Cover Page Interactive Data File (embedded within the inline XBRL document)